Neil Goldstein

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

C.E.M. Griffiths, Bruce Strober, Peter van de Kerkhof et al. · New England Journal of Medicine · 2010 · 851 citations

Medicine, Dermatology, Pharmacotherapy +13

Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis

Désirée van der Heijde, Robert Landewé, Xenofon Baraliakos et al. · Arthritis & Rheumatism · 2008 · 517 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 170 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)

Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease et al. · Annals of the Rheumatic Diseases · 2014 · 127 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two‐year period

Jürgen Braun, Atul Deodhar, Ben A. C. Dijkmans et al. · Arthritis Care & Research · 2008 · 106 citations

Medicine, Clinical Sciences, Pharmacotherapy +7